Loading...
OTCM
RECLF
Market cap95mUSD
, Last price  
USD
Name

ReproCell Inc

Chart & Performance

D1W1MN
OTCM:RECLF chart
P/E
—
P/S
—
EPS
1.09
Div Yield, %
—
Shrs. gr., 5y
5.44%
Rev. gr., 5y
19.94%
Revenues
2.98b
+22.74%
316,524,000420,077,000460,950,000567,001,0001,066,373,0001,257,812,000926,255,0001,088,527,0001,199,908,0001,286,283,0002,234,568,0002,953,271,0002,426,817,0002,978,627,000
Net income
103m
P
-22,206,0005,869,000-133,923,000-451,793,000-1,961,351,000-911,664,000-2,172,046,000-601,424,000-1,016,520,000-812,572,000-575,094,000-305,313,000-31,415,000103,245,000
CFO
6m
P
-13,076,000-375,000-39,042,000-626,798,000-614,376,000-775,025,000-636,720,000-554,831,000-689,803,000-648,883,000-246,244,000-140,534,000-11,451,0006,287,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
URL
https://reprocell.co.jp/
IPO date
Jun 26, 2013
Employees
92
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT